Title : Cell adaptation, attenuation, and vaccine efficacy of a genotype VII virulent Newcastle disease virus isolated in Taiwan
Abstract:
Newcastle disease virus (NDV) is a highly contagious avian pathogen that causes severe respiratory, neurological, and gastrointestinal disorders in chickens, often resulting in high mortality. Currently, genotype VII is the predominant circulating genotype worldwide, particularly in Asia, and has recently spread to Europe. However, the cross-protective efficacy of commercially available vaccines against genotype VII remains suboptimal. In this study, virulent genotype VII field isolates from Taiwan were serially passaged to adapt to BHK21 cell and attenuation. Cytopathic effects (CPE) were continuously monitored during passaging, and viral clones were selected and purified using plaque assays. The final viral titer reached up to 10? TCID??/mL. Pathogenicity was evaluated using the mean death time (MDT) and intracerebral pathogenicity index (ICPI), specifically, MDT values ranged from 99 to 132 hours, and ICPI values were less than 0.8, both of which met the criteria for lentogenic strains. Protective efficacy was further assessed using PD?? assays and cross-protection experiments. Regardless of whether the Sato strain or genotype VII strains were used as challenge viruses, chickens immunized with different doses of the inactivated genotype VII vaccine antigen exhibited complete protection. In cross-protection studies, chickens vaccinated with either the genotype VII vaccine alone or in combination with the traditional Sato strain showed full protection against virulent challenge, whereas the Sato-only vaccinated group exhibited a mortality rate of 14.3%. Overall, these results demonstrate that genotype VII-derived NDV vaccine candidates exhibit strong immunogenicity, high potency, and effective cross-protection, supporting their potential application in NDV vaccine development.

